| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | $152.3M+8.2% | $140.8M+74.9% | $80.5M-25.9% | $108.6M-19.7% | $135.2M+9.9% | $123.0M+104.9% | $60.0M+34.5% | $44.6M-78.0% | $202.7M |
| Cost of sales | $228.8M+43.5% | $159.4M-17.1% | $192.4M+38.1% | $139.3M+71.1% | $81.4M+87.7% | $43.4M-4.8% | $45.5M+349.3% | $10.1M-67.5% | $31.2M |
| Amortization of intangibles | $76.7M+7.9% | $71.0M-3.7% | $73.8M+71.0% | $43.1M | $0 | $0 | — | — | — |
| Research and development | $81.5M+3.1% | $79.0M+3.5% | $76.4M+14.6% | $66.6M+86.7% | $35.7M+4.2% | $34.2M-75.7% | $140.8M-6.3% | $150.3M-0.3% | $150.6M |
| Selling, general and administrative | $207.1M+34.2% | $154.3M+3.5% | $149.2M+3.9% | $143.5M+185.2% | $50.3M+10.0% | $45.7M-40.8% | $77.3M+27.1% | $60.8M+13.0% | $53.8M |
| Impairment of intangible asset | $48.7M | $0 | $0 | — | — | — | — | — | — |
| Acquired in-process research and development expense | $284.9M | $0 | $0 | — | — | — | — | — | — |
| Total operating expenses | $927.6M+100.0% | $463.8M-5.7% | $491.7M+25.2% | $392.6M+134.5% | $167.4M+35.7% | $123.3M-53.2% | $263.6M+19.2% | $221.2M-6.1% | $235.6M |
| Operating income | $469.0M-15.0% | $551.5M+63.4% | $337.6M+26.2% | $267.5M-3.0% | $275.9M+91.3% | $144.3M+313.4% | -$67.6M+2.5% | -$69.3M-185.6% | $81.0M |
| Investment and other income, net | $21.5M-9.6% | $23.8M+45.6% | $16.3M+1459.9% | $1.0M-5.1% | $1.1M-79.7% | $5.4M-22.3% | $7.0M-7.8% | $7.6M+192.4% | $2.6M |
| Inducement expense related to convertible notes | -$5.5M | $0 | $0+100.0% | -$2.7M+87.1% | -$21.0M | $0 | $0 | — | — |
| Contingent liability fair value measurement gain | $0 | $0-100.0% | $13.2M | $0 | $0 | — | — | — | — |
| Interest expense | -$18.1M-0.2% | -$18.1M+3.6% | -$18.8M-10.7% | -$16.9M-125.2% | -$7.5M+63.1% | -$20.4M-75.3% | -$11.6M+35.6% | -$18.0M+17.9% | -$22.0M |
| Income before income tax expense | $466.9M-16.2% | $557.1M+59.9% | $348.3M+39.9% | $248.9M+0.2% | $248.5M+92.2% | $129.3M+279.0% | -$72.3M+9.5% | -$79.8M-229.5% | $61.6M |
| Income tax expense | $150.0M+32.7% | $113.0M+69.4% | $66.7M+42.6% | $46.8M+130.3% | -$154.2M-71156.2% | $217K+2072.7% | -$11K-102.0% | $537K+139.5% | -$1.4M |
| Net income | $316.9M-28.6% | $444.1M+57.7% | $281.6M+39.3% | $202.1M-49.8% | $402.7M+212.0% | $129.1M+278.7% | -$72.2M+10.1% | -$80.3M-227.6% | $63.0M |
| Basic (usd per share) | $2640.00-24.6% | $3500.00+64.3% | $2130.00+43.9% | $1480.00-48.3% | $2860.00+201.1% | $950.00+290.0% | -$500.00+10.7% | -$560.00 | — |
| Diluted (usd per share) | $2560.00-25.4% | $3430.00+63.3% | $2100.00+45.8% | $1440.00-47.4% | $2740.00+201.1% | $910.00+282.0% | -$500.00+10.7% | -$560.00-224.4% | $450.00 |
| Basic (in shares) | 119.8M-5.5% | 126.8M-3.9% | 131.9M-3.6% | 136.8M-2.7% | 140.6M+3.3% | 136.2M-5.6% | 144.3M+0.5% | 143.6M+5.3% | 136.4M |
| Diluted (in shares) | 123.9M-4.3% | 129.4M-3.6% | 134.2M-4.6% | 140.6M-4.2% | 146.8M+3.8% | 141.5M-2.0% | 144.3M+0.5% | 143.6M+3.3% | 139.1M |
| Royalties | |||||||||
| Product sales, net | |||||||||
| Revenues under collaborative agreements | |||||||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.